Abstract:Background: Progressive hearing loss is a common problem in the human population with no effective therapeutics currently available. However, it has a strong genetic contribution, and investigating the genes and regulatory interactions underlying hearing loss offers the possibility of identifying therapeutic candidates. Mutations in regulatory genes are particularly useful for this, and an example is the microRNA miR-96, a post-transcriptional regulator which controls hair cell maturation. Mice and humans carrying mutations in miR-96 all exhibit hearing impairment, in homozygosis if not in heterozygosis, but different mutations result in different physiological, structural and transcriptional phenotypes. Methods: Here we present our characterisation of two lines of mice carrying different human mutations knocked-in to Mir96. We have carried out auditory brainstem response tests to examine their hearing with age and after noise exposure and have used confocal and scanning electron microscopy to examine the ultrastructure of the organ of Corti and hair cell synapses. Bulk RNA-seq was carried out on the organs of Corti of postnatal mice, followed by bioinformatic analyses to identify candidate targets. Results: While mice homozygous for either mutation are profoundly deaf from 2 weeks old, the heterozygous phenotypes differ markedly, with only one mutation resulting in hearing impairment in heterozygosis. Investigations of the structural phenotype showed that one mutation appears to lead to synaptic defects, while the other has a much more severe effect on the hair cell stereociliary bundles. Transcriptome analyses revealed a wide range of misregulated genes in both mutants which were notably dissimilar. We used the transcriptome analyses to investigate candidate therapeutics, and tested one, finding that it delayed the progression of hearing loss in heterozygous mice. Conclusions: Our work adds further support for the importance of the gain of novel targets in microRNA mutants and offers a proof of concept for the identification of pharmacological interventions to maintain hearing.

Absence of hearing loss in a mouse model for DFNA17 and MYH9-related disease: the use of public gene-targeted ES cell resources

Generation and characterization of mice with Myh9 deficiency

The pathogenesis of common Gjb2 mutations associated with human hereditary deafness in mice

Knock-In Mice with Myo3a Y137C Mutation Displayed Progressive Hearing Loss and Hair Cell Degeneration in the Inner Ear

A Humanized Mouse Model, Demonstrating Progressive Hearing Loss Caused by MYO6 P.c442y, is Inherited in a Semi-Dominant Pattern

A mouse model for human hearing loss DFNB30 due to loss of function of myosin IIIA

Phenotypic differences in the inner ears of CBA/CaJ and C57BL/6J mice carrying missense and single base pair deletion mutations in the Cdh23 gene

Pathological mechanisms and candidate therapeutic approaches in the hearing loss of mice carrying human mutations

Grhl2 deficiency impairs otic development and hearing ability in a zebrafish model of the progressive dominant hearing loss DFNA28.

Pathological mechanisms and candidate therapeutic approaches in the hearing loss of mice carrying human MIR96 mutations

GJB2 gene therapy and conditional deletion reveal developmental stage-dependent effects on inner ear structure and function

Characterization of a Knock-in Mouse Model of the Homozygous P.v37i Variant in Gjb2.

Rational design of a genomically humanized mouse model for dominantly-inherited hearing loss, DFNA9

A mouse model for nonsyndromic deafness (DFNB12) links hearing loss to defects in tip links of mechanosensory hair cells.

Mouse Screen Reveals Multiple New Genes Underlying Mouse and Human Hearing Loss.

A murine model for the del(GJB6-D13S1830) deletion recapitulating the phenotype of human DFNB1 hearing impairment: generation and functional and histopathological study

Functional and Developmental Changes in the Inner Hair Cell Ribbon Synapses Caused by Myosin VI Knockout and Deafness-Inducing Point Mutation

Deafness DFNB128 Associated with a Recessive Variant of Human MAP3K1 Recapitulates Hearing Loss of Map3k1-Deficient Mice

Template-independent Genome Editing in the Pcdh15 Mouse, a Model of Human DFNB23 Nonsyndromic Deafness

A Humanized Murine Model, Demonstrating Dominant Progressive Hearing Loss Caused by a Novel KCNQ4 Mutation (p.g228d) from a Large Chinese Family

A novel MYH9 mutation related to non-syndromic delayed post-lingual sensorineural hearing loss